10-Q: Kid Castle Educational Corp Reports Net Income of $1.5 Million Following Sale of Operating Subsidiary

Kid Castle Educational Corporation reports a net income of $1.5 million for the nine months ended September 30, 2024, primarily due to the sale of its main operating subsidiary.

Summary

• Kid Castle Educational Corporation reported a net income of $1,517,143 for the nine months ended September 30, 2024, a significant increase compared to the $668,001 net income for the same period in 2023.
• The company's revenue for the nine months ended September 30, 2024 was $0, compared to $1,135,578 for the same period in 2023.
• The increase in net income is primarily attributed to a $1,560,992 gain from the disposition of an operating subsidiary, Alpharidge Capital LLC.
• Operating expenses decreased to $44,924 for the nine months ended September 30, 2024, from $208,906 in the same period of 2023.
• The company's cash balance as of September 30, 2024, is $0, down from $19,166 at the end of September 2023.
• The company sold Alpharidge Capital LLC for $1,560,992, payable in 240 monthly installments of $6,510, starting July 1, 2024.
• As of September 30, 2024, the company had a working capital of $78,120, consisting of the trade receivable from the sale of Alpharidge Capital LLC.
• The company's accumulated deficit as of September 30, 2024, is $6,121,517.

Sentiment

Score: 5

Explanation: The document presents a mixed picture. While the company achieved a significant net income due to an asset sale, its lack of operational revenue, negative cash balance, and accumulated deficit raise concerns. The need for a capital raise and the presence of internal control weaknesses further temper the positive aspects.

Positives

• The company achieved a net income of $1,517,143 for the nine months ended September 30, 2024, a significant improvement compared to the same period last year.
• The sale of Alpharidge Capital LLC generated a substantial gain of $1,560,992, which will be received over 240 months.
• Operating expenses were significantly reduced to $44,924 for the nine months ended September 30, 2024, indicating improved cost management.
• The company has a working capital of $78,120, primarily from the trade receivable related to the sale of Alpharidge Capital LLC.

Negatives

• The company's revenue for the nine months ended September 30, 2024, was $0, indicating a lack of operational income.
• The company's cash balance is $0 as of September 30, 2024, raising concerns about its immediate liquidity.
• The company has an accumulated deficit of $6,121,517, highlighting its past financial struggles.
• The company's ability to continue as a going concern is dependent on raising additional capital or achieving profitability.

Risks

• The company's ability to continue as a going concern is dependent on raising additional capital or achieving profitability.
• The company has a history of operating losses and an accumulated deficit of $6,121,517.
• The company's cash balance is $0, indicating a need for immediate funding.
• The company's future plans depend on successful acquisitions and rollups, which are not guaranteed.
• The company faces competition from more established companies with greater resources.
• The company has material weaknesses in its internal controls over financial reporting.
• The company is subject to a Wells Notice from the SEC, which could lead to legal action and penalties.

Future Outlook

The company plans to focus on acquiring and rolling up profitable Artificial Intelligence, Machine Learning, Robotics, and digital assets across the United States. The company needs approximately $1,500,000 to sustain operations for the next 12 months and plans to achieve meaningful revenue from acquisitions. The company's ability to continue operations is dependent on raising additional capital or achieving profitability.

Management Comments

• The company's business plan is to help Video River Networks, Inc. (NIHK) achieve its business plan.
• The company will focus on rolling up Artificial Intelligence, Machine Learning, Robotics, and digital assets and businesses in North America.
• The company's principal business objective is to maximize stockholder returns through acquisitions, sustainable growth in cash flows, and potential long-term appreciation in the value of its businesses.
• The company's ability to continue operations will be dependent upon the successfully long-term or permanent capital in form of equity financing, the support of creditors and shareholders, and, ultimately, the achievement of profitable operations.

Industry Context

The company's shift from a CBD-focused business to acquiring and managing assets in real estate, biopharma, and the digital economy reflects a broader trend of companies diversifying their portfolios to capitalize on emerging market opportunities. The focus on AI, machine learning, and robotics aligns with the growing importance of these technologies in various industries. However, the company faces competition from more established players in these sectors.

Comparison to Industry Standards

• The company's lack of revenue from operations is concerning compared to industry standards, where companies typically generate revenue from their core business activities.
• The company's reliance on asset sales for income is not a sustainable long-term strategy, as most companies aim for recurring revenue streams.
• The company's negative cash balance and accumulated deficit are significantly below industry benchmarks for companies with similar aspirations.
• The company's internal control weaknesses are a major concern, as most public companies are expected to have robust internal controls.
• The company's lack of a formal audit committee is also a deviation from standard corporate governance practices.

Legal Proceedings

• The company received a Wells Notice from the SEC, which advised that the staff of the Securities and Exchange Commission has made a preliminary determination to recommend that the Commission file an enforcement action against GiveMePower, Inc.
• The proposed action would allege violations of Securities Act of 1933 and Securities Exchange Act of 1934.
• The Notices recommendation may involve a civil injunctive action and the commission may seek remedies that include an injunction and civil money penalties.

Related Party Transactions

• The company entered into a line of credit agreement in the amount of $1,500,000 with Los Angeles Community Capital, which is controlled by Frank I. Igwealor, Chief Executive Officer of the Company.
• The company sold Alpharidge Capital LLC to American Community Capital, LP., a California limited partnership controlled by our President and CEO Mr. Frank I Igwealor.
• The company shares a leased office with two other organizations that are affiliated to its principal shareholder.

Stakeholder Impact

• Shareholders may be concerned about the company's lack of operational revenue, negative cash balance, and accumulated deficit.
• Employees may be affected by the company's financial instability and potential need for restructuring.
• Creditors may be at risk due to the company's dependence on raising additional capital.
• Customers may be impacted by the company's potential inability to deliver on its business plans.

Next Steps

• The company plans to hire business development managers and an office manager.
• The company plans to acquire and consolidate stakes in at least two select AI, Machine Learning, Robotics, and digital assets and biopharma businesses.
• The company plans to integrate acquired businesses into its model.
• The company plans to identify and acquire complementary/similar businesses or assets in the target market.
• The company plans to run the businesses efficiently and add value to investors and shareholders.
• The company plans to acquire more undervalued businesses, restructure them, and sell them for profit or hold them for cash flow.

Key Dates

Keywords

financial results, net income, operating expenses, asset sale, Alpharidge Capital LLC, going concern, capital raise, internal controls, SEC, acquisition, rollups, digital assets, biopharma, real estate